Hydroalcoholic Extract from Inflorescences of Achyrocline satureioides (Compositae) Ameliorates Dextran Sulphate Sodium-Induced Colitis in Mice by Attenuation in the Production of Inflammatory Cytokines and Oxidative Mediators

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Da Silva, Luisa Mota ^a   Farias, Jaime Antonio Machado ^a   Boeing, Thaise ^a   Somensi, Lincon Bordignon ^a   Beber, Ana Paula ^a   Cury, Benhur Judah ^a   Santin, José Roberto ^a   Faloni De Andrade, Sérgio ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACHYROCLINE SATUREIOIDES EXTRACT; ANTIINFLAMMATORY AGENT; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPID HYDROPEROXIDE; LIPOPOLYSACCHARIDE; MESALAZINE; MUCIN; MYELOPEROXIDASE; NITRIC OXIDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACHYROCLINE; ACHYROCLINE SATUREIOIDES; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLORESCENCE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PROTEIN BLOOD LEVEL; RAT;

EID: 84994652656     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3475356     Document Type: Article

References (56)

1. B. C. Da Silva, A. C. Lyra, R. Rocha, and G. O. Santana, "Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis, " World Journal of Gastroenterology, vol. 20, no. 28, pp. 9458-9467, 2014.
2. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, " Gastroenterology, vol. 142, no. 1, pp. 46-54. e42, 2012.
3. A. Di Sabatino, P. Biancheri, L. Rovedatti, T. T. MacDonald, and G. R. Corazza, "Recent advances in understanding ulcerative colitis, " Internal and Emergency Medicine, vol. 7, no. 2, pp. 103-111, 2012.
4. A. Kornbluth and D. B. Sachar, "Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee, " The American Journal of Gastroenterology, vol. 105, no. 3, pp. 501-523, 2010.
5. J. D. Feuerstein and A. S. Cheifetz, "Ulcerative colitis: epidemiology, diagnosis, and management, " Mayo Clinic Proceedings, vol. 89, no. 11, pp. 1553-1563, 2014.
6. C. Bezzio, F. Furfaro, R. De Franchis, G. Maconi, A. K. Asthana, and S. Ardizzone, "Ulcerative colitis: current pharmacotherapy and future directions, "ExpertOpiniononPharmacotherapy, vol. 15, no. 12, pp. 1659-1670, 2014.
7. H. Sales-Campos, P. J. Basso, V. B. F. Alves et al., "Classical and recent advances in the treatment of inflammatory bowel diseases, " Brazilian Journal of Medical and Biological Research, vol. 48, no. 2, pp. 96-107, 2015.
8. G. Ferraro, C. Anesini, A. Ouviña et al., "Total phenolic content and antioxidant activity of extracts of Achyrocline satureioides flowers from different zones in Argentina, " Latin American Journal of Pharmacy, vol. 27, no. 4, pp. 626-628, 2008.
9. M. Bolson, S. R. Hefler, E. I. Dall'Oglio Chaves, A. Gasparotto Junior, and E. L. Cardozo Junior, "Ethno-medicinal study of plants used for treatment of human ailments, with residents of the surrounding region of forest fragments of Paraná, Brazil, " Journal of Ethnopharmacology, vol. 161, pp. 1-10, 2015.
10. C. Kadarian, A. M. Broussalis, J. Miño et al., "Hepatoprotective activity of Achyrocline satureioides (Lam) D. C., " Pharmacological Research, vol. 45, no. 1, pp. 57-61, 2002.
11. M. Cosentino, R. Bombelli, E. Carcano et al., "Immunomodulatory properties of Achyrocline satureioides (Lam.)D. C. infusion: a study on human leukocytes, " Journal of Ethnopharmacology, vol. 116, no. 3, pp. 501-507, 2008.
12. L. Taylor, The Healing Power of Rainforest Herbs-A Guide to Understanding and Using Herbal Medicinals, Square One, Garden City Park, NY, USA, 2005.
13. C. M. O. Simões, E. P. Schenkel, L. Bauer, and A. Langeloh, "Pharmacological investigations on Achyrocline satureioides (Lam.) DC., compositae, " Journal of Ethnopharmacology, vol. 22, no. 3, pp. 281-293, 1988.
14. E. D. Barioni, J. R. Santin, I. D. Machado et al., "Achyrocline satureioides (Lam.) D. C. hydroalcoholic extract inhibits neutrophil functions related to innate host defense, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 787916, 12 pages, 2013.
15. J. R. Santin, M. Lemos, L. C. K. Júnior, R. Niero, and S. F. de Andrade, "Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models, " Journal of Ethnopharmacology, vol. 130, no. 2, pp. 334-339, 2010.
16. A. Arnous, D. P. Makris, and P. Kefalas, "Effect of principal polyphenolic components in relation to antioxidant characteristics of aged red wines, " Journal of Agricultural and Food Chemistry, vol. 49, no. 12, pp. 5736-5742, 2001.
17. J. L. Lamaison, C. Petijean-Freytet, and A. Carnat, "Teneurs en acide rosmarinique, en dérivés hydroxycinnamiques totaux et activités antioxydantes chez les Apiacées, les Borraginac ées et les Lamiacéesmédicinales, " Annales Pharmaceutiques Françaises, vol. 48, no. 2, pp. 103-108, 1990.
18. B. Chassaing, J. D. Aitken, M. Malleshappa, and M. Vijay-Kumar, "Dextran sulfate sodium(DSS)-induced colitis in mice, " Current Protocols in Immunology, vol. 104, unit 15-25, 2014.
19. M. P. Utrilla, M. J. Peinado, R. Ruiz et al., "Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis, " Molecular Nutrition and Food Research, vol. 59, no. 4, pp. 807-819, 2015.
20. D. Camuesco, M. Comalada, M. E. Rodríguez-Cabezas et al., "The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression, " British Journal of Pharmacology, vol. 143, no. 7, pp. 908-918, 2004.
21. J. Sedlak and R. H. Lindsay, "Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissuewith Ellman's reagent, " Analytical Biochemistry, vol. 25, no. 1, pp. 192-205, 1968.
22. Z.-Y. Jiang, J. V. Hunt, and S. P. Wolff, "Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein, " Analytical Biochemistry, vol. 202, no. 2, pp. 384-389, 1992.
23. S. Marklund and G. Marklund, "Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, " European Journal of Biochemistry, vol. 47, no. 3, pp. 469-474, 1974.
24. M. S. Blois, "Antioxidant determinations by the use of a stable free radical, " Nature, vol. 181, no. 4617, pp. 1199-1200, 1958.
25. F.-A. Chen, A.-B. Wu, and C.-Y. Chen, "The influence of different treatments on the free radical scavenging activity of burdock and variations of its active components, " Food Chemistry, vol. 86, no. 4, pp. 479-484, 2004.
26. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, "Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker, " The Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206-209, 1982.
27. L. M. De Young, J. B. Kheifets, S. J. Ballaron, and J. M. Young, "Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents, " Agents and Actions, vol. 26, no. 3-4, pp. 335-341, 1989.
28. M. B. Grisham, G. G. Johnson, and J. R. Lancaster Jr., "Quantitation of nitrate and nitrite in extracellular fluids, " Methods in Enzymology, vol. 268, pp. 237-246, 1996.
29. H. Zhang, H. Wu, L. Liu, H. Li, D. Q. Shih, and X. Zhang, "1, 25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 andTh17 activation, " APMIS, vol. 123, no. 6, pp. 490-501, 2015.
30. L. Kruidenier, I. Kuiper, C. B. H. W. Lamers, and H. W. Verspaget, "Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants, " The Journal of Pathology, vol. 201, no. 1, pp. 28-36, 2003.
31. Y. Yeom and Y. Kim, "The Sasa quelpaertensis leaf extract inhibits the dextran sulfate sodium-induced mouse colitis throughmodulation of antioxidant enzyme expression, " Journal of Cancer Prevention, vol. 20, no. 2, pp. 136-146, 2015.
32. J. R. Santin, Marivanelemos, L. C. Klein-Júnior et al., "Gastro protective and anti-Helicobacter pylori effects of a flavonoid rich fraction obtained from Achyrocline satureoides (LAM) D. C, " International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 7, pp. 417-422, 2014.
33. N. Goyal, A. Rana, A. Ahlawat, K. R. V. Bijjem, and P. Kumar, "Animal models of inflammatory bowel disease: a review, " Inflammopharmacology, vol. 22, no. 4, pp. 219-233, 2014.
34. G. K. Zorzi, F. Caregnato, J. C. Moreira, H. F. Teixeira, and E. L. Carvalho, "Antioxidant effect of nanoemulsions containing extract of Achyrocline satureioides (Lam) D. C.-asteraceae, " AAPS PharmSciTech, vol. 17, no. 4, pp. 844-850, 2016.
35. C. Casero, F. Machín, S. Méndez-álvarez et al., "Structure and antimicrobial activity of phloroglucinol derivatives from Achyrocline satureioides, " Journal of Natural Products, vol. 78, no. 1, pp. 93-102, 2015.
36. M. J. González, V. G. Beoletto, A. M. Agnese, M. C. Audisio, and J. M. Marioli, "Purification of substances from achyrocline satureioides with inhibitory activity against paenibacillus larvae, the causal agent of american foulbrood in Honeybees' larvae, " Applied Biochemistry and Biotechnology, vol. 175, no. 7, pp. 3349-3359, 2015.
37. J. Bidone, D. F. Argenta, J. Kratz et al., "Antiherpes activity and skin/mucosa distribution of flavonoids from achyrocline satureioides extract incorporated into topical nanoemulsions, " BioMed Research International, vol. 2015, Article ID 238010, 7 pages, 2015.
38. Y. Nishitani, K. Yamamoto, M. Yoshida et al., "Intestinal antiinflammatory activity of luteolin: role of the aglycone in NF-kB inactivation in macrophages co-cultured with intestinal epithelial cells, " BioFactors, vol. 39, no. 5, pp. 522-533, 2013.
39. D. Dodda, R. Chhajed, J. Mishra, and M. Padhy, "Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin, " Indian Journal of Pharmacology, vol. 46, no. 3, pp. 286-291, 2014.
40. H. Yu, L.-H. Wu, Z.-L. Xu, D. Dong, and S.-A. He, "Protective effect of anthocyanins extract from blueberry on TNBSinduced IBD model of mice, " Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 525462, 8 pages, 2011.
41. S. P. L. Travis, "Which 5-ASA" Gut, vol. 51, no. 4, pp. 548-549, 2002.
42. V. G. Pillarisetty, A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo, "Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition, " The Journal of Immunology, vol. 172, no. 2, pp. 1009-1017, 2004.
43. S. Cornick, A. Tawiah, and K. Chadee, "Roles and regulation of the mucus barrier in the gut, " Tissue Barriers, vol. 3, no. 1-2, Article ID e982426, 2015.
44. Y. Merga, B. J. Campbell, and J. M. Rhodes, "Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy, " Digestive Diseases, vol. 32, no. 4, pp. 475-483, 2014.
45. D. R. Clayburgh, L. Shen, and J. R. Turner, "A porous defense: the leaky epithelial barrier in intestinal disease, " Laboratory Investigation, vol. 84, no. 3, pp. 282-291, 2004.
46. A. Bhattacharyya, R. Chattopadhyay, S. Mitra, and S. E. Crowe, "Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases, " Physiological Reviews, vol. 94, no. 2, pp. 329-354, 2014.
47. Y. J. Kim, E.-H. Kim, and K. B. Hahm, "Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities, " Journal of Gastroenterology andHepatology, vol. 27, no. 6, pp. 1004-1010, 2012.
48. J. Zhao, T. Hong, M. Dong, Y. Meng, and J. Mu, "Protective effect ofmyricetin in dextran sulphate sodium-inducedmurine ulcerative colitis, " Molecular Medicine Reports, vol. 7, no. 2, pp. 565-570, 2013.
49. J. Pedersen, M. Coskun, C. Soendergaard, M. Salem, and O. H. Nielsen, "Inflammatory pathways of importance for management of inflammatory bowel disease, " World Journal of Gastroenterology, vol. 20, no. 1, pp. 64-77, 2014.
50. C. Banks, A. Bateman, R. Payne, P. Johnson, and N. Sheron, "Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease, "TheJournal of Pathology, vol. 199, no. 1, pp. 28-35, 2003.
51. R. Sreedhar, S. Arumugam, V. Karuppagounder et al., "Jumihaidokuto effectively inhibits colon inflammation and apoptosis in mice with acute colitis, " International Immunopharmacology, vol. 29, no. 2, pp. 957-963, 2015.
52. L. A. Dieleman, M. J. H. J. Palmen, H. Akol et al., "Chronic experimental colitis induced by dextran sulphate sodium(DSS) is characterized byTh1 and Th2 cytokines, " Clinical and Experimental Immunology, vol. 114, no. 3, pp. 385-391, 1998.
53. K. V. Barros, R. A. N. Xavier, G. G. Abreu et al., "Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium(DSS) colitis, " Lipids inHealth andDisease, vol. 9, article 68, 2010.
54. G. Paul, V. Khare, and C. Gasche, "Inflamed gut mucosa: downstream of interleukin-10, " European Journal of Clinical Investigation, vol. 42, no. 1, pp. 95-109, 2012.
55. J. O. Lindsay, A. Sandison, P. Cohen, F. M. Brennan, and H. J. F. Hodgson, "IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis, " Digestive Diseases and Sciences, vol. 49, no. 7-8, pp. 1327-1334, 2004.
56. H. Groux, A. O'Garra, M. Bigler et al., "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, " Nature, vol. 389, no. 6652, pp. 737-742, 1997.